The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Serine Deprivation Enhances Antineoplastic Activity of Biguanides
Abstract
Metformin, a biguanide widely used in the treatment of type II diabetes, clearly exhibits antineoplastic activity in experimental models and has been reported to reduce cancer incidence in diabetics. There are ongoing clinical trials to evaluate its antitumor properties, which may relate to its fundamental activity as an inhibitor of oxidative phosphorylation. Here, we show that serine withdrawal increases the antineoplastic effects of phenformin (a potent biguanide structurally related to metformin). Serine synthesis was not inhibited by biguanides. Instead, metabolic studies indicated a requirement for serine to allow cells to compensate for biguanide-induced decrease in oxidative phosphorylation by upregulating glycolysis. Furthermore, serine deprivation modified the impact of metformin on the relative abundance of metabolites within the citric acid cycle. In mice, a serine-deficient diet reduced serine levels in tumors and significantly enhanced the tumor growth–inhibitory actions of biguanide treatment. Our results define a dietary manipulation that can enhance the efficacy of biguanides as antineoplastic agents that target cancer cell energy metabolism. Cancer Res; 74(24); 7521–33. ©2014 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, serine deprivation by dietary restriction is sufficient to slow growth of both xenograft (Gravel et al., 2014; Maddocks et al., 2013) and autochthonous cancer models, although efficacy of serine deprivation appears to be influenced by both the oncogenic driver mutation and tissue context (Maddocks et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Gravel et al., 2014
In the citing paper
“Combining serine restriction with other drugs may also potentiate antitumor responses (Gravel et al., 2014; Maddocks et al., 2013; Maddocks et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Gravel et al., 2014
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3557 · Cited by 1,727
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function
Hardie, D. G. (2011) · Genes & Development · doi:10.1101/gad.17420111 · Cited by 1,638
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181
Cited by
Sorted by citations
Items 101–138 of 138
Combination strategies to target metabolic flexibility in cancer
Krstić, J., Schindlmaier, K., & Prokesch, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.03.001 · Cited by 9
Pistoni, M., Tondelli, G., Gallo, C., Torricelli, F., Maresca, A., Carelli, V., Ciarrocchi, A., & Dallaglio, K. (2019) · Melanoma Research · doi:10.1097/cmr.0000000000000624 · Cited by 9
Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
Zhang, J., Bai, J., Chen, G., Wang, J., Cheng, Y., Zhao, J., & Xiong, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1184626 · Cited by 8
Bizjak, M., Malavašič, P., Pirkmajer, S., & Pavlin, M. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.090 · Cited by 8
Gao, X., Sanderson, S. M., Dai, Z., Reid, M. A., Cooper, D. E., Lu, M., Richie, J. P., Ciccarella, A., Calcagnotto, A., Mikhael, P. G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/627364 · Cited by 8
Lin, Z., Chang, C., Zhao, S., Fang, L., & Wang, P. (2025) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2025.0115 · Cited by 10
Reprogramming of leukemic cell metabolism through the naphthoquinonic compound Quambalarine B
Vališ, K., Grobárová, V., Hernychová, L., Bugáňová, M., Kavan, D., Kalous, M., Černý, J., Stodůlková, E., Kuzma, M., Flieger, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21663 · Cited by 7
Metformin alters therapeutic effects in the BALB/c tumor therapy model
Meyer, F., Goebel, S., Spangel, S. B., Leovsky, C., Hoelzer, D., & Thierbach, R. (2021) · BMC Cancer · doi:10.1186/s12885-021-08354-x · Cited by 6
Mechanism and application of nonessential amino acid deprivation associated with tumor therapy
Nong, S., Qian, Y., Zhang, T., Zhou, X., Wei, Y., Yin, X., & Ma, X. (2022) · MedComm – Future Medicine · doi:10.1002/mef2.12 · Cited by 6
Yang, R., Ying, G., & Li, B. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0866-1 · Cited by 6
ASCT2 is the primary serine transporter in cancer cellsPreprint
Conger, K. O., Chidley, C., Ozgurses, M., Zhao, H., Kim, Y., Semina, S. E., Burns, P. A., Rawat, V., Sheldon, R., Ben-Sahra, I., et al. (2023) · bioRxiv · doi:10.1101/2023.10.09.561530 · Cited by 5
Wang, X., Wang, Z., Liu, Z., Huang, F., Pan, Z., Zhang, Z., & Liu, T. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189322 · Cited by 5
ΔNp63α drives serine synthesis to promote carboplatin resistance in NSCLC
Deng, L., Yang, X., Zhang, J., Zhou, X., Ma, R., Wu, Z., & Chen, H. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08497-4 · Cited by 5
Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Li, W., Liu, N., Chen, M., Liu, D., & Liu, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189262 · Cited by 5
Corsetti, G., Romano, C., Codenotti, S., Giugno, L., Pasini, E., Fanzani, A., Scarabelli, T. M., & Dioguardi, F. S. (2024) · Cells · doi:10.3390/cells13141210 · Cited by 5
Ni, C. S., & Li, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22814 · Cited by 4
Subedi, A., Muroi, M., Futamura, Y., Kawamura, T., Aono, H., Nishi, M., Ryo, A., Watanabe, N., & Osada, H. (2019) · FEBS Letters · doi:10.1002/1873-3468.13361 · Cited by 4
Leveraging cancer metabolism to translate into effective therapeutics
Xu, J., Guo, L., Wang, Y., Li, X., Yi, P., & Cheng, C. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.12.003 · Cited by 4
Essentiality of non-essential amino acids for tumour cells and tumorigenesis
Dang, C. V. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0113-0 · Cited by 4
Chang, S. M., Munim, M. B., Trojan, S., Cox, H., Shevzov-Zebrun, A., Abbott, K. L., Chang, R., & Heiden, M. G. V. (2025) · eLife · doi:10.7554/elife.107123 · Cited by 2
Targeting Metabolic Reprogramming: A New Frontier in Cancer Therapy
Thakur, R. K., & Kumari, N. (2025) · Springer eBooks · doi:10.1007/978-981-96-7336-0_9 · Cited by 1
The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance
Jiang, Y., Zhou, G., Zhang, Q., & Zhou, S. (2026) · MedComm – Oncology · doi:10.1002/mog2.70062 · Cited by 1
the effect of in vitro exposure to certain metformin doses on the motility of human spermatozoa
Al-Nashme, F. E., & Al-Jubory, W. A. (2022) · Iraqi Journal of Embryos and Infertility Researches · doi:10.28969/ijeir.v12.i1.r5.22 · Cited by 1
Hulea, L., Gravel, S., Morita, M., Cargnello, M., Uchenunu, O., Im, Y. K., McLaughlan, S., Larsson, O. S., Ohh, M., Ferreira, T., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155732 · Cited by 1
Self-citationChang, S. M., Munim, M. B., Trojan, S., Shevzov-Zebrun, A., Abbott, K. L., & Heiden, M. G. V. (2025) · eLife · doi:10.7554/elife.107123.1 · Cited by 1
Fanale, D., Incorvaia, L., Russo, A. D., Longo, V. D., & Mirisola, M. G. (2021) · UNIPA Springer series · doi:10.1007/978-3-030-56051-5_25
TSE, C. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.60060
Dietary Strategy for Cancer Therapy - Amino Acid Restrictions and beyond
Li, S., & Kang, J. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223910124090003
Chang, S. M., Munim, M. B., Trojan, S., Cox, H., Shevzov-Zebrun, A., Abbott, K. L., Chang, R., & Heiden, M. G. V. (2026) · eLife · doi:10.1101/2025.05.09.653205
Additional file 1 of Metformin alters therapeutic effects in the BALB/c tumor therapy model
Meyer, F. B., Goebel, S., Spangel, S. B., Leovsky, C., Hoelzer, D., & Thierbach, R. (2021) · Figshare · doi:10.6084/m9.figshare.14691850
Additional file 2 of Metformin alters therapeutic effects in the BALB/c tumor therapy model
Meyer, F. B., Goebel, S., Spangel, S. B., Leovsky, C., Hoelzer, D., & Thierbach, R. (2021) · Figshare · doi:10.6084/m9.figshare.14691853
Haitzmann, T., Schindlmaier, K., Frech, T., Mondal, A., Bubalo, V., Konrad, B., Bluemel, G., Stiegler, P., Lackner, S., Hrzenjak, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26696289
Haitzmann, T., Schindlmaier, K., Frech, T., Mondal, A., Bubalo, V., Konrad, B., Bluemel, G., Stiegler, P., Lackner, S., Hrzenjak, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25459513
Additional file 4 of Dietary restriction of amino acids for Cancer therapy
Kang, J.-S. (2020) · Figshare · doi:10.6084/m9.figshare.11984706
Haitzmann, T., Schindlmaier, K., Frech, T., Mondal, A., Bubalo, V., Konrad, B., Bluemel, G., Stiegler, P., Lackner, S., Hrzenjak, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26696292
Haitzmann, T., Schindlmaier, K., Frech, T., Mondal, A., Bubalo, V., Konrad, B., Bluemel, G., Stiegler, P., Lackner, S., Hrzenjak, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25459328
Sun, C., Wu, S., Li, Z., Huang, C., & Wu, D. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118376
Metadata
- Authors
- Gravel, S.-P., Hulea, L., Toban, N., Birman, E., Blouin, M.-J., Zakikhani, M., Zhao, Y., Topisirovic, I., St-Pierre, J., & Pollak, M.
- Affiliations
- McGill University (CA)
- Jewish General Hospital (CA)
- 2Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
- 1Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.
- 3Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
- Venue
- Cancer Research
- Published
- 2014-12-14
- Volume
- 74
- Issue
- 24
- Pages
- 7521-7533
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2016133306
- Cited by
- 138
- References
- 47
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 14 · 2022: 15 · 2021: 24 · 2020: 15 · 2019: 13 · 2018: 8 · 2017: 7 · 2016: 11 · 2015: 5
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (MOP115-195, FRN53888, 106603_1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- biguanides, metformin, phenformin, anticancer activity, oxidative phosphorylation inhibition, glycolysis, cancer cell energy metabolism, tumor growth inhibition, dietary intervention
- MeSH terms
- Animals, Biguanides, Glycolysis, Humans, Metformin, Neoplasms, Oxidative Phosphorylation, Phenformin, Serine, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
